Cargando…

Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews

IMPORTANCE: Selective serotonin reuptake inhibitors (SSRIs) are a commonly prescribed medication class to treat a variety of mental disorders. However, adherence to SSRIs is low, and uncovering the reasons for discontinuation among SSRI users is an important first step to improving medication persis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golder, Su, Medaglio, Dominique, O’Connor, Karen, Hennessy, Sean, Gross, Robert, Gonzalez Hernandez, Graciela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352861/ https://www.ncbi.nlm.nih.gov/pubmed/37459097 http://dx.doi.org/10.1001/jamanetworkopen.2023.23746

Ejemplares similares

Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media
por: Golder, Su, et al.
Publicado: (2022)

Assessment of Beliefs and Attitudes About Statins Posted on Twitter: A Qualitative Study
por: Golder, Su, et al.
Publicado: (2020)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice
por: Collins, Helen M, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Comparison of the neurobiological effects of attribution retraining group therapy with those of selective serotonin reuptake inhibitors
por: Wang, C., et al.
Publicado: (2013)

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants
por: Oskotsky, Tomiko, et al.
Publicado: (2021)

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
por: Feduccia, Allison A., et al.
Publicado: (2020)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
por: Golder, Su, et al.
Publicado: (2020)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Public Perspectives on Anti-Diabetic Drugs: Exploratory Analysis of Twitter Posts
por: Golder, Su, et al.
Publicado: (2021)

Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents
por: Lee, Kyung Hwa, et al.
Publicado: (2023)

Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin(4) Receptor Agonists in the Rat
por: Lucas, Guillaume, et al.
Publicado: (2010)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved
por: Renoir, Thibault
Publicado: (2013)

Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia
por: Mathys, Monica, et al.
Publicado: (2018)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
por: Vasudev, Rahul, et al.
Publicado: (2016)

Ankle edema after administration of selective serotonin reuptake inhibitors
por: Kontoangelos, Konstantinos, et al.
Publicado: (2018)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
por: Nguyen, Thanh Thanh L., et al.
Publicado: (2021)

Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Jannini, Tommaso B., et al.
Publicado: (2022)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Two Cases of Decreased (123)I-Metaiodobenzylguanidine Lung Uptake in Metaiodobenzylguanidine Scintigraphy While Taking Selective Serotonin Reuptake Inhibitor/Serotonin Noradrenaline Reuptake Inhibitor
por: Adaniya, Shinobu, et al.
Publicado: (2021)

Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report
por: Meng, Yuki, et al.
Publicado: (2021)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8cj9o2t29sn2ng3qdjeqelqn1i